CBDBY(CBDBY)
CBDBY
No analyst ratings available
No analyst price targets available for CBDBY
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $19.75B | $20.82B | $20.68B |
| Low | $19.11B | $20.15B | $20.00B |
| High | $20.41B | $21.52B | $21.36B |
| EBITDA Avg | $2.46B | $2.59B | $2.58B |
| Low | $2.38B | $2.51B | $2.49B |
| High | $2.54B | $2.68B | $2.66B |
| EBIT Avg | $432M | $455M | $452M |
| Low | $418M | $440M | $437M |
| High | $446M | $470M | $467M |
| Net Income Avg | $-358M | $-187M | $-98M |
| Low | $-373M | $-195M | $-103M |
| High | $-343M | $-179M | $-94M |
| EPS Avg | $-0.80 | $-0.42 | $-0.22 |
| Low | $-0.84 | $-0.44 | $-0.23 |
| High | $-0.77 | $-0.40 | $-0.21 |
| Analysts (Rev / EPS) | 4 / 1 | 2 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $4.73B | $5.52B |
| Low | $4.73B | $5.52B |
| High | $4.73B | $5.52B |
| EBITDA Avg | $589M | $687M |
| Low | $589M | $687M |
| High | $589M | $687M |
| EBIT Avg | $103M | $121M |
| Low | $103M | $121M |
| High | $103M | $121M |
| Net Income Avg | $-72M | $-6M |
| Low | $-72M | $-6M |
| High | $-72M | $-6M |
| EPS Avg | $-0.15 | $-0.01 |
| Low | $-0.15 | $-0.01 |
| High | $-0.15 | $-0.01 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |